George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 156.40
Bid: 156.20
Ask: 156.40
Change: 2.00 (1.30%)
Spread: 0.20 (0.128%)
Open: 152.40
High: 156.40
Low: 152.40
Prev. Close: 154.40
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

14 Jul 2022 13:49

RNS Number : 5247S
Templeton Emerging Markets IT PLC
14 July 2022
 

Templeton Emerging Markets Investment Trust PLC

Legal Entity Identifier (LEI): 5493002NMTB70RZBXO96

 

14 July 2022

 

Result of Annual General Meeting

 

The Board of Templeton Emerging Markets Investment Trust PLC (the "Company") announces that, at the Annual General Meeting of the Company held on 14 July 2022, all of the following resolutions were passed by the requisite majority.

 

Resolution

Votes for (including votes at the discretion of the Chairman)

 

%

Votes Against

%

Total Votes Cast

% of Issued Share Capital Voted

Votes Withheld

Ordinary Resolutions

1. To receive and adopt the Directors' and Auditor's Reports and financial statements for the year ended 31 March 2022.

749,912,832

99.86%

1,017,660

0.14%

750,930,492

58.66%

40,258

2. To approve the Directors' Remuneration Report for the year ended 31 March 2022.

749,695,535

99.86%

1,056,931

0.14%

750,752,466

58.65%

218,284

3. To declare a final dividend of 2.80 pence per share for the year ended 31 March 2022.

750,864,280

99.99%

68,140

0.01%

750,932,420

58.66%

38,330

4.1 To re-elect Paul Manduca as a Director.

738,185,547

98.33%

12,523,971

1.67%

750,709,518

58.64%

261,232

4.2 To re-elect Charlie Ricketts as a Director.

743,807,695

99.08%

6,943,009

0.92%

750,750,704

58.65%

220,046

4.3 To re-elect David Graham as a Director.

743,825,704

99.08%

6,894,255

0.92%

750,719,959

58.65%

250,791

4.4 To re-elect Simon Jeffreys as a Director.

719,599,623

95.86%

31,106,140

4.14%

750,705,763

58.64%

264,987

4.5 To re-elect Magdalene Miller as a Director.

743,757,827

99.07%

6,985,616

0.93%

750,743,443

58.65%

227,307

5. To re-appoint Ernst & Young LLP as auditor of the Company, to act until the conclusion of the next general meeting of the Company at which audited accounts are laid before the members.

749,378,578

99.08%

1,477,464

0.20%

750,856,042

58.66%

114,708

6. To authorise the Directors to determine the auditor's remuneration.

750,553,702

99.96%

332,548

0.04%

750,886,160

58.66%

84,590

Special Business

Ordinary Resolution

7. To authorise the Directors to allot shares.

750,552,553

99.96%

327,347

0.04%

750,879,900

58.66%

90,850

Special Resolution

8. To disapply pre-emption rights in relation to the allotment of shares by the Directors.

745,275,895

99.26%

5,535,468

0.74%

750,811,363

58.65%

159,387

Special Resolution

9. To authorise the Company to purchase its own shares.

749,471,531

99.81%

1,460,324

0.19%

750,931,855

58.66%

38,895

Special Resolution

 10. That a general meeting, other than an annual general meeting, may be called on not less than 14 clear days' notice.

748,393,573

99.66%

2,527,135

0.34%

750,920,708

58.66%

50,042

The total number of voting rights at the proxy deadline was 1,176,267,868

 

For further information please e-mail temitcosec@franklintempleton.com or contact Client Dealer Services at Franklin Templeton on free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors, or e-mail enquiries@franklintempleton.co.uk.

END OF ANNOUNCEMENT

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKQBQBBKDOOD
Date   Source Headline
26th Apr 20244:59 pmRNSTransaction in Own Shares
26th Apr 20248:38 amRNSNet Asset Value(s)
25th Apr 20248:52 amRNSNet Asset Value(s)
24th Apr 20244:58 pmRNSTransaction in Own Shares
24th Apr 20248:40 amRNSNet Asset Value(s)
23rd Apr 20244:58 pmRNSTransaction in Own Shares
23rd Apr 20249:27 amRNSNet Asset Value(s)
22nd Apr 20245:02 pmRNSTransaction in Own Shares
22nd Apr 202410:08 amRNSPortfolio Update
22nd Apr 20248:46 amRNSNet Asset Value(s)
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:46 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:52 pmRNSTransaction in Own Shares
17th Apr 20249:03 amRNSNet Asset Value(s)
16th Apr 20245:05 pmRNSTransaction in Own Shares
16th Apr 20248:36 amRNSNet Asset Value(s)
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 20249:00 amRNSNet Asset Value(s)
12th Apr 20244:51 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:54 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:53 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20245:02 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:53 pmRNSTransaction in Own Shares
8th Apr 20248:49 amRNSNet Asset Value(s)
5th Apr 20248:46 amRNSNet Asset Value(s)
4th Apr 20248:43 amRNSNet Asset Value(s)
3rd Apr 20244:13 pmRNSHolding(s) in Company
3rd Apr 20249:15 amRNSNet Asset Value(s)
2nd Apr 20245:00 pmRNSTransaction in Own Shares
2nd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20249:16 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20249:11 amRNSNet Asset Value(s)
27th Mar 20245:01 pmRNSTransaction in Own Shares
27th Mar 20249:04 amRNSNet Asset Value(s)
26th Mar 20245:03 pmRNSTransaction in Own Shares
26th Mar 20249:10 amRNSNet Asset Value(s)
25th Mar 20244:54 pmRNSTransaction in Own Shares
25th Mar 20248:59 amRNSNet Asset Value(s)
22nd Mar 20244:56 pmRNSTransaction in Own Shares
22nd Mar 20248:23 amRNSNet Asset Value(s)
21st Mar 20248:54 amRNSNet Asset Value(s)
20th Mar 20245:00 pmRNSTransaction in Own Shares
20th Mar 20249:40 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.